Last checked at 11 Jul 2018 07:00
11 July 2018
Accrol Group Holdings plc
("Accrol" or the "Group")
AIM: ACRL
Notice of Final Results
Accrol, the leading independent tissue converter in the UK, will announce its Final Results for the year ended 30 April 2018 on Wednesday, 26 September 2018, which will include a full update on the progress of the Group's turnaround.
As previously announced, the Board continues to expect that the Group's underlying EBITDA for the year ended 30 April 2018 will be in line with market expectations.
Enquiries:
Accrol Group Holdings plc | Tel: +44 (0) 1254 278 844 |
Dan Wright, Executive Chairman |
|
Gareth Jenkins, Chief Executive Officer |
|
Steve Townsley, Chief Financial Officer |
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
|
|
Belvedere Communications Limited | Tel: +44 (0) 203 567 0510 |
Catriona Valentine (cvalentine@belvederepr.com) |
|
Llewellyn Angus (langus@belvederepr.com) |
|
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.
Accrol operates from three sites:
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.